Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs

Fumiaki Kumagai, Takefumi Suzuki, W. Wolfgang Fleischhacker, Norio Yasui-Furukori, Masaru Mimura, Hiroyuki Uchida

Research output: Contribution to journalArticle

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs'. Together they form a unique fingerprint.

Medicine & Life Sciences